logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 20 of 68 Items
Showing 1 - 20 of 68 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Protocol

Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme (‘ENABLE 1.5’) – study protocol

Mandi H, Asogun D, Ayodeji O, Azuogu BN, Camacho A,  et al.
2025-07-31 • BMJ Public Health
2025-07-31 • BMJ Public Health

INTRODUCTION

Lassa fever (LF), a viral haemorrhagic disease, poses a significant public health challenge in West Africa. Lassa virus infection frequently causes...

Conference Material
|
Slide Presentation
Conference Material
|
Video

Antibiogo as an innovative solution to detect antimicrobial resistance: from an operational need to a CE-marked diagnostic test available for low-income and middle-income countries

Malou N
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Abstract
Conference Material
|
Video

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
Journal Article
|
Protocol
Journal Article
|
Short Report
Journal Article
|
Letter
Journal Article
|
Research
Journal Article
|
Short Report
Journal Article
|
Commentary
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research

'Atomic bombs' in Monrovia, Liberia: the identity and stigmatisation of Ebola survivors

Venables E
Journal Article
|
Research

Survivors' Perceptions of Public Health Messages During an Ebola Crisis in Liberia and Sierra Leone: An Exploratory Study

Conference Material
|
Poster
Journal Article
|
Research
Journal Article
|
Commentary
Journal Article
|
Commentary
Journal Article
|
Research

Antibiogo as an innovative solution to detect antimicrobial resistance: from an operational need to a CE-marked diagnostic test available for low-income and middle-income countries

Rapoud D, Cramer E, Al Asmar M, Sagara F, Ndiaye B,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa causing an estimated 300 000 to 500 000 cases and 5 000 fataliti...

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol

Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN,  et al.
2023-03-30 • PLOS One
2023-03-30 • PLOS One
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities every year. The true prevalence and i...

Possible sexual transmission of Ebola virus - Liberia, 2015

Christie A, Davies-Wayne GJ, Cordier-Lassalle T, Blackley DJ, Laney AS,  et al.
2015-05-08 • Morbidity and Mortality Weekly Report
2015-05-08 • Morbidity and Mortality Weekly Report

Shedding of Ebola Virus in an Asymptomatic Pregnant Woman

Akerlund E, Prescott JB, Tampellini L
2015-06-18 • New England Journal of Medicine
2015-06-18 • New England Journal of Medicine

Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières

O'Brien DP, Venis S, Greig J, Shanks L, Ellman T,  et al.
2010-06-17 • Conflict and Health
2010-06-17 • Conflict and Health
INTRODUCTION
Many countries ravaged by conflict have substantial morbidity and mortality attributed to HIV/AIDS yet HIV treatment is uncommonly available. Universal access to HIV car...

Evidence for a decrease in transmission of Ebola virus — Lofa County, Liberia, June 8–November 1, 2014

Sharma A, Heijenberg N, Peter C, Bolongei J, Reeder B,  et al.
2014-11-14 • Morbidity and Mortality Weekly Report
2014-11-14 • Morbidity and Mortality Weekly Report
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?
Lofa County in Liberia has one of the highest numbers of reported cases of Ebola virus disease (Ebola) in West Africa. Government health offic...

Clinical Field Research in a Post-conflict Setting

Boggero M
2010-10-01 • Global Policy
2010-10-01 • Global Policy

Psychological distress among Ebola survivors discharged from an Ebola treatment unit in Monrovia, Liberia - a qualitative study

Rabelo I, Lee VS, Fallah MP, Massaquoi M, Evlampidou I,  et al.
2016-07-04 • Frontiers in Public Health
2016-07-04 • Frontiers in Public Health
INTRODUCTION
A consequence of the West Africa Ebola outbreak 2014–2015 was the unprecedented number of Ebola survivors discharged from the Ebola Treatment Units (ETUs). Liberia alone...

Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004

Huhn GD, Brown J, Perea W, Berthe A, Otero H,  et al.
2006-02-06 • Vaccine
2006-02-06 • Vaccine
Yellow fever (YF) is a mosquito-borne vaccine-preventable disease with high mortality. In West Africa, low population immunity increases the risk of epidemic transmission. A cluster surv...
2017-06-01 • Anthropology in Action
2017-06-01 • Anthropology in Action
Survivors of the Ebola virus have been widely profiled as the success stories of the outbreak, yet they still face challenges relating to their identity and reintegration. A survivor’s b...
Schwerdtle PN, De Clerck V, Plummer V
2017-09-20 • Nursing and Health Sciences
2017-09-20 • Nursing and Health Sciences
The outbreak of Ebola virus disease in Guinea, Liberia, and Sierra Leone was the largest epidemic of Ebola ever recorded. The healthcare workforce was diminished and exhausted as the reg...

Magnesium sulphate as an adjunct to treatment of tetanus in children

Goodyer J, Pont T, Lah ED, Mayronne S, Carreras I
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022

Clinical chemistry of patients with Ebola in Monrovia, Liberia

de Wit E, Kramer S, Prescott JB, Rosenke K, Falzarano D,  et al.
2016-07-28 • Journal of Infectious Diseases
2016-07-28 • Journal of Infectious Diseases
The development of point-of-care clinical chemistry analyzers has enabled the implementation of these ancillary tests in field laboratories in resource-limited outbreak areas. The Eterna...

A tale of two cities: restoring water services in Kabul and Monrovia

Pinera JF, Reed RA
2009-07-27 • Disasters
2009-07-27 • Disasters
Kabul and Monrovia, the respective capitals of Afghanistan and Liberia, have recently emerged from long-lasting armed conflicts. In both cities, a large number of organisations took part...

The use of Ebola convalescent plasma to treat Ebola Virus Disease in resource constrained settings: a perspective from the field

van Griensven J, De Weiggheleire A, Delamou A, Smith PJ, Edwards T,  et al.
2015-08-10 • Clinical Infectious Diseases
2015-08-10 • Clinical Infectious Diseases
The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola Virus Disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone and Liberia, was ...

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.<...